)
Michael G. King
Director of Research, Senior Biotechnology Analyst
Rodman & Renshaw
Michael G. King Jr. is Director of Research and a Senior Biotechnology Analyst at Rodman & Renshaw. He brings more than 25 years of experience in biotechnology and healthcare equity research, advising investors and corporate management teams across market capitalizations and therapeutic categories. Over the course of his career, Mr. King has held senior research leadership roles at multiple Wall Street firms, including Bank of America, JMP Securities, and Robertson Stephens. He also previously served as Head of Research at Rodman & Renshaw from 2005 to 2009.
In addition to his sell-side research background, Mr. King has held operating and strategic roles within the biotechnology industry, including serving as Entrepreneur in Residence at Fortress Biotech and as Chief Financial Officer of SAB Biotherapeutics. He has been recognized for his work by The Wall Street Journal’s “Best on the Street” analyst survey and by Institutional Investor.
Mr. King earned a B.A. in Finance from the Bernard M. Baruch College of the City University of New York.
Sessions
-
24-Jun-202624BCOncology Investment Trends: Where Is the Industry Making Its Bets?
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}